Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study
Open Access
- 1 January 2018
- journal article
- research article
- Published by Taylor & Francis in SAHARA-J: Journal of Social Aspects of HIV/AIDS
- Vol. 15 (1) , 128-137
Abstract
The acceptability of lifelong antiretroviral therapy (ART) among HIV-positive women in high-burden Nigeria, is not well-known. We explored readiness of users and providers of prevention of mother-to-child transmission of HIV (PMTCT) services to accept lifelong ART -before Option B plus was implemented in Nigeria. We conducted 142 key informant interviews among 100 PMTCT users (25 pregnant-newly-diagnosed, 26 pregnant-in-care, 28 lost-to-follow-up (LTFU) and 21 postpartum women living with HIV) and 42 PMTCT providers in rural North-Central Nigeria. Qualitative data were manually analyzed via Grounded Theory. PMTCT users had mixed views about lifelong ART, strongly influenced by motivation to prevent infant HIV and by presence or absence of maternal illness. Newly-diagnosed women were most enthusiastic about lifelong ART, however postpartum and LTFU women expressed conditionalities for acceptance and adherence, including minimal ART side effects and potentially serious maternal illness. Providers corroborated user findings, identifying the postpartum period as problematic for lifelong ART acceptability/adherence. Option B plus scale-up in Nigeria will require proactively addressing PMTCT user fears about ART side effects, and continuous education on long-term maternal and infant benefits. Structural barriers such as the availability of trained providers, long clinic wait times and patient access to ART should also be addressed.Keywords
Funding Information
- National Institute of Health's Fogarty International Center (D43 TW 01041)
- World Health Organization (WHO RPC 531)
This publication has 29 references indexed in Scilit:
- Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, MalawiPLOS ONE, 2016
- Fundamental concerns of women living with HIV around the implementation of Option B+Journal of the International AIDS Society, 2015
- The Impact of Mentor Mother Programs on PMTCT Service Uptake and Retention-in-Care at Primary Health Care Facilities in NigeriaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in MalawiAIDS, 2014
- Women's Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B+ in Dar es Salaam, TanzaniaPLOS ONE, 2014
- Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in TanzaniaBMC Public Health, 2013
- Is Option B+ the best choice?The Lancet, 2013
- Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countriesAIDS, 2012
- Using Audience-Segmentation Techniques to Tailor Health Behavior Change StrategiesAmerican Journal of Health Behavior, 2000
- Social Marketing: A Tool for Health EducationAmerican Journal of Health Behavior, 2000